Cohort Company News - MedTech Innovator

Neurescue’s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest

DateJun 10 2021

Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency control of hemorrhage.

Malaysian startup Naluri raises US$5mil in Series A round

DateJun 09 2021

NALURI Hidup Sdn Bhd, a Malaysia-headquartered digital health service provider, today announced the closing of its new, US$5 million (RM20.6 million) funding round.

CloudCath Announces Collaboration with American Renal Associates in Pre-Market Clinical Study for Peritoneal Dialysis Patients

DateJun 08 2021

CloudCath, developer of a remote monitoring and predictive analytics platform for catheter-based treatments, today announced a collaboration with American Renal Associates (ARA), a leading provider of outpatient dialysis services.

A Conversation With Sana Health’s Richard Hanbury

DateJun 08 2021

For me, the Sana Health device was truly a gift from the universe. I’ve been very open about my struggles with pain stemming from my autoimmune disorders and I was extremely grateful when representatives at Sana connected with me and offered to send me a device to help with my healing.

Localized Prostate Cancer Therapy: Interview with Shyam Natarajan, CEO of Avenda Health

DateJun 07 2021

Avenda Health, a medtech company based in Santa Monica, California has developed the Focal Therapy System. It provides AI-powered prostate cancer therapy with the aim of treating only tumorous tissues, while reducing side-effects compared with conventional therapies. The system recently received FDA breakthrough designation.

Medical Device Company FineHeart Successfully Raises €15 million

DateJun 02 2021

FineHeart S.A, a preclinical medical device company that has developed theICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced the successful completion of a €15 million funding round.

Empirical Spine Closes $10 Million Series B Financing

DateJun 02 2021

Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced the closing of a Series B financing of $10 million.

Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President

DateJun 02 2021

Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH), today announced that it has closed a $24 million Series B financing round.

PAVmed Launches Digital Health Company Veris Health Inc.

DateJun 02 2021

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the launch of a new subsidiary, digital health company Veris Health Inc. (“Veris”), which acquired Oncodisc Inc. (“Oncodisc”), a digital health company with groundbreaking tools to improve personalized cancer care through remote patient monitoring.

Medical device-maker Allotrope Medical raises $4M Series A round

DateJun 01 2021

Houston-based medical device company Allotrope Medical Inc. raised a $4 million funding round, the firm announced June 1.

Venari Medical: Galway medtech with a potentially life-changing device

DateMay 24 2021

NUI Galway BioInnovate spin-out Venari Medical has developed a minimally invasive medical device that it hopes can tackle CVD at early and extreme stages.

BrainSee Enterprise Software Is Reliable, Accurate for Alzheimer’s Disease Detection, featuring Darmiyan

DateMay 24 2021

Today the American Society of Neuroradiology published Introducing BrainSee, a summary of study results presenting the 91 percent accuracy rate of the new AI-powered and patented technology by Darmiyan Inc. that detects Alzheimer’s disease at early stages of disease development.

Forest Devices Announces That FDA Has Designated the AlphaStroke Technology a Breakthrough Device

DateMay 21 2021

Medical technology pioneer Forest Devices, Inc. (FDI), a medical device company focused on identifying patients with large vessel occlusive (LVO) strokes in the prehospital environment, today announced that the U.S. Food and Drug Administration (FDA) has designated its AlphaStroke technology as a Breakthrough Device.

Colorado Awards $8.6M in Grants to Startups, featuring Orbit Genomics

DateMay 21 2021

Thirty-six Colorado startups secured almost $8.6 million in grants as part of the Colorado Office of Economic Development and International Trade’s Advanced Industries Accelerator Program.

Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences

DateMay 17 2021

Alleviant Medical Inc., a privately-held medical device company, today announced one-month and three-month follow up data from the first in human clinical study (ALLEVIATE-HF-1) of its technology for the treatment of heart failure with preserved ejection fraction (HFpEF).

This imaging device could be a breakthrough for breast cancer treatment, featuring OncoRes Medical

DateMay 14 2021

Having breast surgery to remove a cancerous lump is traumatic enough. Learning that you’ll need another operation to remove cancer cells that the surgeon couldn’t detect the first time only adds to the worry — and the cost.

Avenda Health’s Male ‘Lumpectomy’ Receives Breakthrough Device Designation

DateMay 13 2021

Avenda Health has been awarded Breakthrough Device Designation for a male “lumpectomy” product in development designed to treat prostate cancer in-office while preserving quality of life.

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials

DateMay 13 2021

PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve (PTV) for children, announced that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million patients around the world.

Bigfoot Scores FDA Clearance for Diabetes Management System

DateMay 12 2021

Bigfoot Biomedical is a company that MD+DI readers should be quite familiar with by now. In 2017, the diabetes company was selected as the readers' choice for Medtech Company of the Year. The company is developing products to optimize insulin dosing and provide automated insulin delivery for people with insulin-requiring diabetes.

Mindera Raises Over $12M Series A-2 Financing

DateMay 12 2021

Mindera Corporation today announced a $12.6M Series A-2 capital raise. The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development.